FPR2 and metabolic dysfunction-associated steatotic liver disease: However, the Fpr2 amount was still elevated in females compared with males during CDAHFD feeding (Fig. 3b, c), indicating that estrogen-stimulated Fpr2 seems to at least partially compensate for Fpr2 loss by CDAHFD, and prevents female mice from NAFLD progression.